Nautilus Biotechnology, Inc. (NAUT): Price and Financial Metrics
NAUT Price/Volume Stats
| Current price | $0.74 | 52-week high | $3.09 |
| Prev. close | $0.77 | 52-week low | $0.66 |
| Day low | $0.74 | Volume | 144,800 |
| Day high | $0.80 | Avg. volume | 151,960 |
| 50-day MA | $0.77 | Dividend yield | N/A |
| 200-day MA | $1.79 | Market Cap | 93.60M |
NAUT Stock Price Chart Interactive Chart >
Nautilus Biotechnology, Inc. (NAUT) Company Bio
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating platform technology for quantifying and unlocking the complexity of the proteome. It operates Nautilus Proteomic Analysis Platform, an integrated single-molecule protein analysis platform that leverages a nanofabricated, large-scale, single-molecule protein array, multi-cycle imaging, and machine learning analysis to potentially identify and quantify the proteome. The company was founded in 2016 and is headquartered in Seattle, Washington.
NAUT Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NAUT Price Returns
| 1-mo | 5.73% |
| 3-mo | -38.33% |
| 6-mo | -65.42% |
| 1-year | -72.39% |
| 3-year | -78.86% |
| 5-year | N/A |
| YTD | -55.95% |
| 2024 | -43.81% |
| 2023 | 66.11% |
| 2022 | -65.25% |
| 2021 | -52.26% |
| 2020 | N/A |